March 2007:
March 29th:
Rockeby Receives European CE Mark for Human Flu Antigen Detection Test
read article >
March 29th:
Official Name Change To Progen Pharmaceuticals Limited
read article >
March 29th:
Optiscan FIVE 1 Progress Confirms Second Commercialisation
read article >
March 26th:
Metabolic's Pain Drug ACV1 Enters Second Phase 2 Human Clinical Trial
read article >
March 26th:
Mike Taverner Resigns As Non-Executive Director Of Biosignal
read article >
March 22nd:
Rockeby Biomed Update On Anheal Acquisition
read article >
March 20th:
Stem Cell Sciences Opens Dual Listing Share Offer On ASX
read article >
March 18th:
New Oncology Application Identified For CUV1647
read article >
March 14th:
Pharmaxis Reports Phase II Results For Aridol In COPD
read article >
March 14th:
Imugene Avian Influenza Vaccine Update
read article >
March 13th:
BrainZ Extends Distribution Agreement With GE Healthcare
read article >
March 12th:
PI-88 Data To Be Presented at Key International Conferences
read article >
March 5th:
Benitec Issues Rights To Raise $6.5m
read article >
March 5th:
IM MEDICAL Acquires New Generation Cardiovascular Diagnostic Technology
read article >
|
